Dr Steve Ryder describes new treatments for Hepatitis C currently in trials and new devices used for assessment. He then provides coherent and convincing arguments to urge clinicians to get more deeply involved in clinical research. Finally, Dr Ryder summarises the key drivers that promote successful engagement with the pharmaceutical industry.
Dr Ryder is Consultant Physician in Hepatology and Gastroenterology at Nottingham University Hospitals NHS Trust. He is also Chair of the NIHR Hepatology Specialty Group.
Dr Ryder is Consultant Physician in Hepatology and Gastroenterology at Nottingham University Hospitals NHS Trust. He is also Chair of the NIHR Hepatology Specialty Group.
No comments:
Post a Comment